Combined kidney liver transplant in the MELD era: Where are we going?

Liver Transplantation

Volumn 11, Issue 9, 2005, Pages 1022-1025

  Gonwa, Thomas A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IMMUNOSUPPRESSIVE AGENT; VASOPRESSIN DERIVATIVE;

CREATININE BLOOD LEVEL; EDITORIAL; GLOMERULOSCLEROSIS; GRAFT REJECTION; HEPATORENAL SYNDROME; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER DISEASE; LIVER TRANSPLANTATION; NEPHROTOXICITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL TECHNIQUE; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; HUMANS; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; MIDDLE AGED; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 25144461152     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20454     Document Type: Editorial

References (19)

1. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
2. Nair S, Verma S, Thulavath PJ. Pretransplant renal failure predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1186.
3. Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, et al. Preoperative factors associated with outcome and their impact on resource use in 1143 consecutive primary liver transplants. Transplantation 2001;72:1112-1113.
4. Gonwa TA, Klintmalm GB, Levy MF, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995;59: 361-365.
5. Brown RS, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996;62:1788-1793.
6. Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation Clin Nephrol 1997;48:159-164.
7. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, et al. Hepatorenal Syndrome: combined liver kidney transplantation versus isolated liver transplant. Transplantation 1997;1760-1765.
8. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation 2001;71:1424-1428.
9. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transpl 2002;8:193-211.
10. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 1991;51:428-430.
11. Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. Combined liver-kidney transplantation: what are the indications? Transplantation 1997;64:1091-1096.
12. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation. Transplantation 1998;66:59-66.
13. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-Stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Transplantation 2001;72:1934-1939.
14. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940.
15. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis is the strongest modifiable risk factor for renal transplant outcomes. A paired donor kidney analysis. Transplantation 2002;27:1377-1381.
16. Campbell MS, Kotlyar DS, Brensinger CM, Lewis J, Shetty K, Bloom RD, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005;11:1048-1055.
17. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, et al. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study. Kidney Int 2003;63:1508-1515.
18. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Liver Transpl 2002;8:91-109.
19. Restuccia T, Ortega R, Guerva M, Gines P, Alessandria C, Ozdogan O, et al. Effects of treatment of hepatorenal syndrome before transplantation on post transplantation outcome. A case-control study. J Hepatol 2004;40:140-146.